Erythroderma is an inflammatory skin disease with redness and scaling that affects nearly the entire cutaneous surface. This term applies when 90% or more of the skin is affected.
Erythroderma 是一種罕見但嚴重的皮膚病。雖然確切的原因通常未知,但它可能是由藥物反應或潛在的癌症引發的。與剝脫性皮膚炎相關的常見癌症是皮膚 T 細胞淋巴瘤,在皮膚病開始後數月甚至數年可能不會出現症狀。通常,需要住院進行初步評估和治療。藥物引起的疾病患者通常具有良好的長期前景,但沒有明確病因的病例往往會復發和緩解的病程。癌症相關病例的預後通常取決於癌症的進展。 Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
它通常表現出廣泛的發紅和剝落,覆蓋身體 90% 以上。這種情況是各種潛在健康問題的明顯跡象,例如牛皮癬、濕疹或對某些藥物的反應。 It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
紅皮症最常見的原因是潛在皮膚病的惡化,例如牛皮癬、接觸性皮膚炎、脂漏性皮膚炎、扁平苔癬、毛髮紅糠疹或藥物反應,例如使用外用類固醇。原發性表現較少見,通常見於皮膚 T 細胞淋巴瘤病例。由於將其與皮膚 T 細胞淋巴瘤區分開來非常重要,因此需要進行活檢。